Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - Midatech Pharma US Inc. | Financial_Report.xls |
10-K - FORM 10-K - Midatech Pharma US Inc. | d285235d10k.htm |
EX-23 - CONSENT OF ERNST & YOUNG LLP - Midatech Pharma US Inc. | d285235dex23.htm |
EX-32 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - Midatech Pharma US Inc. | d285235dex32.htm |
EX-31.1 - CERTIFICATION PURSUANT TO SECTION 302 - Midatech Pharma US Inc. | d285235dex311.htm |
EX-31.2 - CERTIFICATION PURSUANT TO SECTION 302 - Midatech Pharma US Inc. | d285235dex312.htm |
EX-10.25 - CHANGE IN CONTROL AGREEMENT - Midatech Pharma US Inc. | d285235dex1025.htm |
Exhibit 21
SUBSIDIARIES OF DARA BIOSCIENCES, INC.
Jurisdiction of Organization/ | ||
Name of Subsidiary |
State of Incorporation | |
DARA Pharmaceuticals, Inc. |
Delaware | |
DARA Therapeutics, Inc. |
North Carolina | |
Oncogenerix, Inc. |
Nevada | |
Point Therapeutics Massachusetts, Inc. |
Massachusetts |